Sunshine Biopharma Receives Health Canada Approval for Generic Ondansetron to Treat Chemotherapy-Induced Nausea

MT Newswires Live
07/28

Sunshine Biopharma (SBFM) said Tuesday that Health Canada has approved its generic Ondansetron tablets of 4 milligrams and 8 milligrams for the Canadian market.

Ondansetron is intended to treat nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery, the company said, adding that it works by blocking the actions of chemicals in the body that trigger nausea and vomiting.

Shares of Sunshine Biopharma were up 2.6% pre-bell.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10